BioSpace News Archive

Telo Genomics Corp. (TSX-V: TELO) (the “Company” or “TELO”) is pleased to announce that it has received final approval and grant of three of its pending patent applications including:

Children’s Hospital Los Angeles surgeon, Lorraine Kelley-Quon, MD, forms team of health care providers and community advocates to establish recommendations for safe opioid use

Nektar Therapeutics (Nasdaq: NKTR) today announced four data presentations for its I-O pipeline from three separate clinical-stage investigational agents at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting.

The new IsoSpark instrument makes IsoPlexis’ unique functional proteomics accessible to every lab, providing an integrated and flexible solution for accelerating curative medicines.

TELA Bio, Inc. (“TELA”) (Nasdaq: TELA), a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today reported financial results for the third quarter ended September 30, 2020.

Dialco’s DIMI receives FDA 510(k) clearance for use in hospital and clinical settings – a significant step in the full regulatory development of DIMI

SenesTech, Inc., a developer of proprietary technologies for managing animal pest populations through fertility control, announced that it has elected three new directors to its Board of Directors, in a move to position the Board to best support the commercial growth of ContraPest®, SenesTech’s lead fertility control product.

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that it is hosting an R&D Symposium on November 12, 2020 from 11:00 am - 1:00 pm ET (8:00 - 10:00 am PT) to highlight its COVID-19 program data,

LENSAR, Inc. announced that three posters and a paper have been accepted for virtual presentations at the Annual Meeting of the American Academy of Ophthalmology being held November 13-15, 2020.

OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in three upcoming virtual investor conferences.